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 Networks of neurons known as central pattern generators (CPGs) generate rhythmic 
patterns of output to drive behaviors like locomotion and respiration. These CPGs are relatively 
fixed networks of neurons that produce consistent, stereotypical patterns in the absence of other 
inputs. The heart contractions of the American lobster (Homarus americanus) are neurogenic 
and controlled by a CPG known as the cardiac ganglion. Neuromodulators (e.g. amines, amino 
acids, and neuropeptides) can enable flexibility in CPG motor output, thereby allowing 
organisms to adjust to changes in their environment or sensory input. Neuromodulators have 
been shown not only to exert effects on CPGs, but also to alter muscle contractions by acting on 
the neuromuscular junction and the muscle itself.  
A tissue-specific transcriptome gleaned from the cardiac ganglion and cardiac muscles of 
the American lobster was used to predict sites and sources of a variety of crustacean 
neuromodulators. Using a bioinformatics workflow, putative neuropeptides and receptors were 
predicted utilizing the transcriptomes and then inferences were made about their potential 
modulatory effects on the periphery of the cardiac neuromuscular system. If corresponding 
receptors were predicted to be expressed in the cardiac muscle, then it was hypothesized that the 
neuropeptide had peripheral effects. Receptors determined to be located at the cardiac muscle 
included those for the following peptides and amines: C-type Allatostatin (AST-C), bursicon, 
DH31, DH44, myosuppressin, octopamine (β receptor), octopamine-tyramine combo, and 
serotonin.  
One peptide that has been extensively studied and for which a cardiac muscle receptor 
was identified is myosuppressin. Myosuppressin has been shown to have modulatory effects at 
the cardiac neuromuscular system of the American lobster. In the whole heart preparation, 
myosuppressin was found to enhance the contraction force. In the isolated cardiac ganglion, 
myosuppressin increased burst duration and decreased cycle frequency and thus, the duty cycle 
of the action potential bursts. Myosuppressin also has modulatory effects on the periphery of 
cardiac neuromuscular system alone. It remains an open question of whether myosuppressin acts 
on the cardiac muscle directly, if it is exerting its effects at the neuromuscular junction (NMJ), or 
both.  
To test this, I performed physiological experiments on the isolated NMJ. Myosuppressin 
did not modulate the amplitude of the excitatory junction potentials. Since I did not observe any 
effects at the NMJ, I next tested the effects of myosuppressin on the cardiac muscle. By isolating 
the cardiac muscle from cardiac ganglion CPG and then stimulating muscle contractions using L-
glutamate, I showed that myosuppressin increased contraction amplitude. Therefore, these data 







Chapter 1: Introduction 
1.1-Central pattern generators 
Organisms’ ability to perform critical rhythmic behaviors that are necessary for survival, 
like locomotion and respiration, are driven by neural networks that generate rhythmic motor 
patterns. These networks of neurons are known as central pattern generators (CPGs). CPGs are 
relatively fixed networks of neurons that produce consistent, stereotypical patterns in the absence 
of other inputs.  
The synaptic connections made between the neurons in a CPG can produce differing 
rhythmic activity based on which specific neurons are active. One common motif is the firing of 
pacemaker neurons that inhibit other network neurons and cause an oscillatory pattern (Marder et 
al., 2001; Smith et. al. 1991).  This oscillatory theory explains the contraction and relaxation of 
muscles that produces rhythmic movement. The neurons in a motor CPG network innervate 
muscle and drive contractions. The network of neurons, motor efferents, and the innervated 
muscle comprise the CPG-effector system.  
CPG-effector systems, which are present in in both vertebrates and invertebrates, produce 
rhythmic behaviors that need to be flexible to allow organisms to adjust to changes in the 
environment and sensory input (Dickinson, 2006). Neuromodulators like peptides and amines 
acting on the CPG-effector system enable flexibility in the motor outputs. In some cases, 
neuromodulators have been shown to activate the CPG circuit and alter muscle movements by 
acting directly on the peripheral effector system, which is composed of both the neuromuscular 
junction and the muscle (e.g. Bishop et al., 1984; Dickinson et al., 2015; Erxleben et al., 1995; 
Jorge-Rivera and Marder, 1996).   
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1.2-The lobster’s heart as a CPG-effector system 
  The simplicity of invertebrate CPG-effector systems makes the American lobster 
(Homarus americanus) an optimal experimental model. The lobster’s heart is part of an open 
circulatory system in which the hemolymph, which acts as the blood of the lobster, flows in 
through the ostia, dorsally and ventrally located on the heart, and is pumped out through the 
anterior and posterior arteries (Figure 1). Unlike the human heart, which can contract 
independent of any neural input (myogenic), the lobster cardiac neuromuscular system is 
neurogenic and therefore muscle contractions are generated by neuronal input (Cooke, 2002). 
This neural input comes from a cluster of neurons on the heart wall known as the cardiac 
ganglion. The cardiac ganglion is one of the CPGs found in the lobster. It is a network of nine 
neurons with four small, posterior pacemaker interneurons (Small Cells) and five large, anterior 
motor neurons (Large Cells) arranged in a Y shape (Figure 1) (Cooke, 2002). Axons extend 
beyond the ganglion, where they innervate and make synapses with the cardiac muscle (Yazawa 
et al., 1999).  
The pacemaker interneurons spontaneously generate bursts of action potentials that drive 
the behavior of the motor neurons through both electrical and excitatory chemical synapses 
(Cooke, 2002). In Hartline’s (1967) investigation of the neural activity at the cardiac ganglion, it 
was discovered that the soma of the motor neurons is electrically unexcitable; action potentials 
can only be initiated at the spike initiating zone located on the proximal axon. Driver potentials 
in this region provide the underlying depolarization within the cells that can bring the membrane 
potential over threshold at the spike initiating zone to cause a burst of sodium-based action 
potentials. Driver potentials are long, sustained potentials mediated by calcium currents and three 
different outward potassium currents: an early voltage-dependent A-current, a voltage dependent 
delayed outward K-current, and a smaller, slow outward C current (Tazaki and Cooke, 1986). 
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Since the five motor neurons are electrically coupled, they fire these bursts synchronously. The 
activity of the motor neurons acts on the cardiac muscle to cause a contraction in a unidirectional 
manner.  
The CPG-effector system is a closed feedback system (Figure 2). The increased calcium 
concentration caused by enhanced muscle contraction results in the activation of a negative 
feedback pathway. Increased calcium elicits the release of nitric oxide, which in turn decreases 
the cycle frequency of contraction by acting on the cardiac ganglion (Mahadevan et al. 2004). 
The muscle stretch also activates mechanosensitive receptors that provide feedback to the cardiac 
ganglion and are thought to be a positive feedback pathway (Maynard, 1960). The dendrites, or 
collateral processes, of the pacemaker and motor neurons are key players in sending signals to 
the muscle fibers to activate this stretch feedback pathway (Hartline, 1979; Cooke, 2002; 
Yazawa et al., 1999). The intrinsic feedback pathways are an important aspect of the CPG-
effector system in stabilizing the heart’s activity.  
Various neuropeptides and amines can modulate the CPG-effector system’s contractile 
response and currents (Harris-Warrick et al, 1991). If neuromodulators are acting at any point in 
the CPG-effector system, their modulation could alter the activity of subsequent regions. 
However, the outputs are not always the same for each region within the CPG-effector system. 
For example, Fort et al. (2007) discovered that the neuromodulator CCAP exerts counteracting 
effects in the different regions of the cardiac neuromuscular system to ultimately stabilize the 




By observing the different ways that neuromodulators regulate each region of the CPG-
effector system, we can gain more insight into the intrinsic and extrinsic mechanisms that drive 
the changes in the rhythmic behaviors. 
1.3- Physiology of the Neuromuscular Junction Physiology 
 The neuromuscular junction (NMJ) is the chemical synapse between the motor neuron 
and the muscle fiber (Worden, 1998). The presynaptic axon terminal of the NMJ is identified by 
a protein dense structure, which aids in the docking of transmitter loaded vesicles (Jahromi & 
Atwood, 1974). There are varying numbers of active zones on the presynaptic membrane, with 
some having no active zones at all (Levitan and Kaczmarek, 2015). The number of active zones 
available at the presynaptic cleft determine how much transmitter is released and the magnitude 
of the postsynaptic response. In crustaceans, the postsynaptic response to transmitter release is a 
depolarization of the muscle membrane potential known as an excitatory junction potential 
(EJP).  
In vertebrates, the well-known transmitter that stimulates EJPs is acetylcholine; however, 
in crustaceans, glutamate serves as the neurotransmitter for many NMJs to drive muscle 
contractions. Glutamate rapidly increases sodium currents, causing a rapid depolarization in the 
muscle followed by a steadier repolarization (Jan & Jan, 1976; Titlow & Robin, 2018). The EJP 
amplitude is determined by a variety of factors, including the amount of transmitter released 
from the presynaptic cell, the density of receptors on the postsynaptic membrane, the resistance 
of the postsynaptic membrane, and the presence of recirculating modulators. The amplitude can 
also vary based on the type of muscle response (e.g. spiking or graded muscle contractions) 
(Titlow & Robin, 2018).  
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When the neuron experiences repetitive stimuli, there is often an increase in transmitter 
release, which is hypothesized to cause facilitation. Facilitation is thought to occur when 
repeated action potentials result in calcium build-up at release sites, which does not have enough 
time to return to lower, unstimulated levels before the next stimulus (Levitan and Kaczmarek, 
2015). Thus, there is residual calcium in the presynaptic cell. The extra calcium then acts on a 
neuronal calcium sensor protein (CaS), which enhances the activity of the calcium channels and 
causes more calcium to enter the synaptic membrane with every action potential. Each 
subsequent EJP at the NMJ is more enhanced than the last until the CaS reaches a point of 
saturation or the stimulus ceases (Figure 3).  
1.4-Muscle Physiology: Cardiac Striated Muscle 
The cardiac muscle of the American lobster is striated muscle. Crustacean cardiac striated 
muscles are non-propagating fibers, so neural input controls the force of contraction (Millar et al. 
2005). Muscle contractions are graded.  
Neuromodulators have been shown to alter muscle activity by modulating calcium 
dynamics (Levitan and Kaczmarek, 2015). Contractions are controlled by levels of calcium 
within the muscle fibers. When the muscle fibers are depolarized by CPG-generated action 
potentials, calcium is released from sarcoplasmic reticulum. The sarcoplasmic reticulum 
sequesters calcium within the muscle fiber, limiting the amount of free calcium within the cell. 
Once released, free calcium binds to the contractile protein and elicits the contraction.   
Neuromodulators acting on the cardiac neuromuscular system could influence any step of 
this muscle contraction, some of the most obvious being the neurotransmitter release and calcium 
dynamics in the muscle.  
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1.5- Peptidergic Modulation 
A well-studied group of neuromodulators is the neuropeptides. Peptides are chains of 
amino acids that are covalently bound. Neuropeptides are encoded as chains of amino acids that 
have signal sequences at their (N)-terminus and are known as preprohormones (Christie et al. 
2010). Once synthesized, the preprohormones go through post translational processing, where 
enzymes cleave the peptide at specific sites, making smaller chains of peptides. Many of these 
peptides then undergo post-translational modifications, which are known to alter the peptide 
structure, making the peptide biologically active and stabilizing it for cellular interactions and 
neural output. Common structural changes in crustaceans can include disulfide bridges between 
cysteines residues, tyrosine sulfation, and C- terminal amidation (Christie et al. 2010). 
 These neuropeptides can modulate the cardiac neuromuscular system at both an intrinsic 
and extrinsic level (Katz, 1995). In H. americanus, intrinsic neuromodulators are synthesized and 
released at the cardiac ganglion, then they act directly on the cardiac ganglion to control their 
own modulation. Extrinsic modulators can be released: locally and/or hormonally. Hormonally 
released extrinsic modulators are synthesized outside the cardiac neuromuscular system and 
released into the hemolymph to travel through the circulatory system to reach the target cells. 
The hormonally released neuromodulators can act on multiple target CPGs. Locally released 
extrinsic modulators are synthesized and released in other regions of the nervous system (e.g. 
thoracic ganglion) that have nerves going into the cardiac ganglion, where they are released at 
the nerve terminals in the cardiac ganglion. Additionally, these modulators act on receptors in 
peripheral regions and not at the cardiac ganglion. 
By knowing the sites and sources of modulation, predictions can be made about whether 
the neuromodulator modulates at the axon terminal, postsynaptic site, or the cardiac muscle. 
Modulators acting at the axon terminal in the effector system have receptors located at the 
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presynaptic membrane of the NMJ and will be referred to as presynaptic modulators. Presynaptic 
modulators can alter the calcium influx, the number of active zones, and the extent to which the 
muscle depolarizes (Levitan and Kaczmarek, 2015). While modulators acting at the postsynaptic 
site or muscle have receptors at the postsynaptic region of muscle and will be referred to as 
postsynaptic modulators. Postsynaptic modulators can affect the receptor availability, the muscle 
membrane resistance, and affinity of receptors. Neuromodulators could also regulate the muscle 
function directly, altering the calcium dynamics, including modulation of the calcium 
concentration that enters the muscle, the internal handling of calcium, or the affinity of troponin 
for calcium. Increasing the amount of calcium bound through any of those pathways would result 
in a larger contraction even with the same sized depolarization and/or amount of glutamate 
released (Levitan and Kaczmarek, 2015).  
Tissue-specific transcriptomes (e.g. cardiac ganglion and cardiac muscle) can be used to 
make inferences about putative peptides’ site(s) of action. However, it becomes difficult to 
determine a neuromodulator’s specific actions if receptors are located at both cardiac ganglion 
and the cardiac muscle. If modulation is postsynaptic, it could be acting on either the cardiac 
muscle or the NMJ. Tissue-specific transcriptomes cannot be made for the NMJ, due to mRNA 
being located in the cell bodies and not the terminal; thus, bioinformatic cannot make predictions 
about receptors located at this region. Bioinformatics also cannot determine the pathways at 
which a neuromodulator alters the muscle contraction. Thus, to determine whether 
neuromodulators act at the NMJ or directly affect the muscle contraction, physiological 
experiments that isolate these regions are necessary. However, there are very few studies in 
which these experiments have been performed. One of these few studies was Wilkens et al. 
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(2005), who showed that proctolin exerts effects on the periphery. They performed physiological 
experiments that determined that proctolin exerted its effects on both the NMJ and the muscle.  
1.6- Tissue-Specific Transcriptomics and Bioinformatics Utilized to Identify Putative 
Neuropeptides and Receptors 
To determine whether specific neuropeptides are likely to act as intrinsic or extrinsic 
modulators in a CPG-effector system, tissue-specific transcriptomes have been analyzed. 
Transcriptomics is a method in which the first step is to extract messenger RNA (mRNA) from 
the tissue of interest. The mRNA holds the genetic information that leads to the formation of 
proteins like neuropeptides and receptors. The Dickinson lab has collaborated with researchers at 
the University of Hawaii at Manoa, who have used in silico transcriptomics to identify peptide 
sequences at a large scale (Christie et al., 2015). With this method, the Dickinson lab and 
collaborators were able to predict a variety of neuropeptides and receptors present within the 
motor and pacemaker cells of the cardiac ganglion, cardiac muscle, eyestalk, brain, and other 
tissues in the American lobster (Christie et al., 2015; Christie et al., 2017; Oliesky et al., 2020).  
Using a bioinformatics workflow, putative neuropeptides or receptors can be predicted 
from transcriptomes. Bioinformatics can also be used to make inferences about the structural 
characteristics and location of the putative peptides and receptors. Through understanding the 
potential localization of neuropeptides’ synthesis and release, predictions can be made about 
their potential modulatory roles. Predicting the location of receptors can indicate the sites of 
modulation for corresponding neuropeptides and whether they are intrinsic or extrinsic 
modulators. Even though bioinformatics is a useful tool for preliminary research, it is necessary 




Using physiological methods, many neuromodulators have been shown to affect the 
periphery; however, they have not been studied in detail. One such neuromodulator is the highly 
conserved peptide, myosuppressin. Myosuppressin, characterized by its C terminal motif- 
HVFLRFamide, is a well-studied neuropeptide in decapods and is a part of the FMRFamide-like 
peptide family (Stevens et al., 2009). Oliesky et al. (2020) identified five putative myosuppressin 
receptors in the brain-, eyestalk ganglia-, and cardiac ganglion-specific transcriptomes of H. 
americanus. The distribution of these five myosuppressin receptors differed among the 
pacemaker and motor neurons of the cardiac ganglion. Differing responses to myosuppressin 
were also observed when studying the pacemaker and motor neurons separately.  
Myosuppressin characteristically drives inhibitory responses in the muscle of various 
arthropod species (Tanaka, 2016). However, in the cardiac neuromuscular system of the 
American lobster, myosuppressin often results in muscular excitation. In the isolated whole 
heart, for example, myosuppressin caused an increase the contraction amplitude (Figure 4). In an 
isolated cardiac ganglion preparation, myosuppressin resulted in an increase in burst duration 
and a decrease in cycle frequency of the action potential bursts (Stevens et al., 2009). 
 Stevens et al. (2009) also demonstrated that myosuppressin exerts modulatory effects at 
the periphery. To isolate the periphery for experimentation, they eliminated all endogenous 
cardiac ganglion activity, then stimulated the motor nerve to elicit transmitter release, causing a 
single contraction for each stimulating burst. Myosuppressin was then superfused over the 
lobster’s heart, resulting in an increase in the amplitude of contraction from baseline (Figure 5).  
Although myosuppressin modulates the muscle contractions, it remains unclear whether the site 
of action is the NMJ, the muscle, or both.  
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The objective of these experiments was twofold. Firstly, I used bioinformatics to generate 
a list of potential neuromodulators that may affect the cardiac neuromuscular system. I 
determined whether they were predicted to be intrinsic or extrinsic modulators, and whether 
receptors were in the cardiac ganglion or the cardiac muscle. Based on these results, I selected a 
neuromodulator that was predicted to be present in both the cardiac ganglion and the cardiac 
muscle and physiologically known to exert effects at the cardiac ganglion and the periphery. Yet 
this selected neuromodulator’s effects at the periphery (NMJ and/or the muscle) remained 
unknown. One such peptide that met these parameters was myosuppressin. Myosuppressin was 
predicted to have receptors located on the cardiac ganglion and the cardiac muscle. Based on this 
information and previous literature, it was predicted that myosuppressin exerted effects on both 
the NMJ and the cardiac muscle. Physiological experiments were performed to determine the 














Chapter 2: Methods 
2.1- Animals 
Lobsters (H. americanus) were purchased from seafood retailers in Brunswick, ME, and 
were kept in a tank of recirculating seawater at 10-12 °C. They were fed scallops and shrimp 
once a week.  
2.2- Bioinformatics 
2.2.1- Tissue Specific Transcriptomics    
The H. americanus tissue-specific transcriptomes were assembled by Dr. Patsy 
Dickinson’s lab, along with collaborator Dr. Andrew Christie’s lab. The mRNA was extracted 
from brain, eyestalk, cardiac ganglion, and cardiac muscle tissue (Christie et al., 2015; Christie et 
al., 2017). The mRNA reads were used to generate tissue-specific transcriptomes, which are 
publicly available on the Hawaii database (http://clc01.pbrc.hawaii.edu/cgi-bin/blast/blast.html). 
In order to predict the sites and sources of putative neuropeptides in the cardiac neuromuscular 
system, the transcriptomes of the cardiac ganglion and the cardiac muscle were analyzed. 
 2.2.2- Bioinformatics Workflow  
 Using a well-vetted bioinformatics workflow, specific neuropeptides and receptors were 
searched for using the transcriptome sequences. An established precursor sequence of the protein 
of interest was used as the query sequence. Precursor protein sequences were either extracted 
from the H. americanus transcriptome or a well-established Drosophila melanogaster 
transcriptome (Veenstra, 2016; https://www.uniprot.org/; http://flybase.org/blast/). Using the 
University of Hawaii Manoa BLAST software, the specific H. americanus tissue transcriptome 
assembly was blasted using a tblastn against the query sequence. The program produced Trinity 
numbers linked to aligning nucleotide sequences. The nucleotide sequence that corresponded to 
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the Trinity number was translated into an amino acid sequence using the program Expasy 
(https://web.expasy.org/translate). Expasy produces six possible open reading frames (three 
forward and three reverse). The longest sequence was selected because that is conceivably the 
sequence that translates into the protein of interest. The selected open reading frame sequence 
was aligned with its query sequence using the MAFFT alignment software 
(https://mafft.cbrc.jp/alignment/software/). The amino acid sequences that were identical was 
indicated by an asterisk (‘*’). The percent identity was calculated based on the similarity in 
alignment. If there was a percent identity above 80 percent, the neuromodulator or receptor 
would be predicted to be synthesized or present in the tissue. Using reciprocal blast programs, 
the unknown proteins were blasted against known proteins using Flybase and NCBI Blast to 
compare and make predictions about the identity of the unknown protein (Christie et al., 2015). 
Using the program Flybase (http://flybase.org/blast/), the neuropeptide and receptor sequences 
were compared to D. melanogaster annotated proteins.  Using NCBI Protein Blast 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi), the proteins were blasted using a blastp and then 
compared to non-redundant arthropods proteins, which allowed for a larger scale search.  
2.2.3- Neuropeptides  
 Preprohormones, once cleaved by enzymes, become smaller peptides that undergo post 
translational modifications that are known to cause changes in the peptide’s modulatory effects. 
Enzyme cleavage sites were predicted based on the programs used (detailed below) and research 
in Christie et al. (2017), which analyzed the transcriptomes of the eyestalk ganglia of the 
American lobster. SignalP 5.0 (http://www.cbs.dtu.dk/services/SignalP/) and Neuropred 
(http://stagbeetle.animal.uiuc.edu/cgi-bin/neuropred.py) software predicted the signal peptide 
that promotes cleavage at that region. Using Expasy’s Sulfinator program 
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(https://web.expasy.org/sulfinator/), sites of tyrosine sulfation within the protein sequences were 
predicted. “DiANNA” (http://clavius.bc.edu/~clotelab/DiANNA/) compares the putative peptide 
isoforms to the current sequence and helped predict the disulfide bond formation between 
cysteine residues. Other cleavage sites were manually predicted from previous research that 
predicted common sites of cleavage like X-X-K-R↓, R-X-X-R↓, R-X-X-X-X-R↓, and RR↓ (‘↓’ 
indicates the point of cleavage) (Veenstra, 2000).  
2.2.4- Receptors  
 Using the following programs, the characteristics and location of putative receptors were 
predicted. The program WOLFpsort (https://wolfpsort.hgc.jp/) software was used to make 
inferences about the location of the receptor within the cell (Wu et al., 2015). Using the program 
Pfam (http://pfam.xfam.org/search/sequence), the specific structure of the receptor was 
predicted. Many of the receptors were identified as 7 transmembrane receptors, indicating that 
they are most likely G protein-coupled receptors (GPCRs). GPCRs usually signal a secondary 
messenger pathway to exert their effect. Further investigations into the GPCRs were done with 
the program TOPCONS (https://topcons.cbr.su.se/), which combines five topology methods 
(OCTOPUS, Philius, PolyPhobius, SCAMPI, and SPOCTOPUS). The topology of the receptors 
and the number of times the receptor passes through the cell membrane was estimated (Tsirigos 
et al., 2015).  
2.3 Physiological Experiments 
2.3.1- Lobster Heart Dissection and Experimental Set Up 
  For physiological experimentation, the lobsters were anesthetized in ice for ~30 minutes. 
The heart, which is located anterior to the tail and dorsally situated, was removed from the body 
and detached from the carapace. The heart remained attached to the hypodermis and was placed 
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in a bath of physiological lobster saline (composition in mM: 479.12 NaCl, 12.74 KCl, 13.67 
CaCl2, 20.00 MgSO4, 3.91 Na2SO4, 11.45 Trizma base, and 4.82 maleic acid; pH 7.45). Under 
a dissecting microscope, the heart was opened to visualize the intact cardiac ganglion and the 
muscle fibers.  
 A Rabbit peristaltic pump (Gilson, Middleton, WI) was used to superfuse saline over the 
cardiac neuromuscular system at a rate of approximately 5ml/min. A Peltier temperature 
regulator (CL-100 bipolar temperature controller and SC-20 solution heater/cooler; Warner 
Instruments, Hampden, CT) was used to cool the saline. Due to the lobster’s thermal sensitivity, 
it was critical that the saline temperature was maintained at 10-10.5oC to keep the cardiac 
ganglion activity stable (Johnson et al., 1991; Tang et al., 2010; Oellermann et al., 2020).  
2.3.2- Myosuppressin Preparation  
Myosuppressin (pQDLDHVFLRFamide; MW = 1272.46 g/mol) was synthesized by 
GenScript Corporation (Piscataway, NJ) and was stored as a stock solution at 10-3M and stored at 
-20oC. Myosuppressin is relatively insoluble in water, so to make the stock solution, it was 
dissolved in DMSO (15%) and deionized water. For experiments, stock solutions were diluted in 
lobster saline to 10-7M. 
2.3.3- The neuromuscular junction 
To visualize the activity at the NMJ, the EJPs were recorded using a microelectrode filled 
with squid cytoplasmic fill (20 mM NaCl, 15 mM Na2SO4, 10 mM Hepes, 400 mM potassium 
gluconate, 10 mM MgCl2) (Hooper et al., 2015). The electrode was inserted into a single muscle 
fiber. The intracellular activity was monitored by using an AxoClamp 2B amplifer (Axon 
Instruments, Molecular Devices, LLC., San Jose, CA).  
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However, before inserting the microelectrode, the cardiac ganglion was removed to 
eliminate spontaneous EJPs (Figure 6A). The motor nerve ending was then stimulated using a 
model 2100 Isolated Pulse Stimulator (A-M System, Sequim, WA) to elicit a contraction of the 
muscle fibers in which it innervates. The intracellular electrode was then inserted into one of 
those muscle fibers. The resting membrane potentials of the muscle fibers were between -30 and 
-70 mV.  
To evoke EJPs, the motor nerve ending was stimulated with three stimulating pulses, 
resulting in three EJPs (Figure 6B). Each stimulation had a duration of 5 x 10-4 seconds and an 
inter-pulse period of 0.4 seconds. Because each motor nerve required a different threshold 
voltage to reliably generate an EJP, a range of voltages were required across preparations (2-7 
V). Every 10 seconds, the three stimuli were delivered using a burst width of 1.1 seconds.  Once 
the preparation was stable for experimentation, myosuppressin was superfused over each 
preparation for 20 minutes (Stevens et al., 2009). To ensure that the preparation’s activity 
returned to baseline, a 40-minute saline wash was imposed. 
2.3.4- Investigating the role of the cardiac muscle 
 To determine whether myosuppressin exerts an effect directly on the muscle, the cardiac 
muscle contractions were measured in the absences of neuronal input using methods that were 
adapted from Maguire (2019). The heart of the lobster was opened to visualize the cardiac 
muscle and cardiac ganglion. A bundle of healthy cardiac muscle was located (either the left or 
right longitudinal cardiac muscle), and hooks were glued perpendicular to each end of the bundle 
using GluTure topical tissue adhesive (Zoetis Inc., Kalamazoo, MI) (Figure 7). For gluing, the 
muscle fiber bundle was dried so that there was no physiological saline in the region that was to 
be glued. Glue was allowed to dry to the muscle for 30 seconds before reapplying saline. A hook 
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attached to a force transducer was perpendicularly placed gently on the center of the bundle. The 
SI-H optical force transducer (WPI Inc., Sarasota, FL) measured the extent to which the muscle 
contracted. The force transducer was calibrated to measure the force of contraction in grams. 
 Since the cardiac ganglion drives the contraction of the cardiac muscle, the cardiac 
ganglion was completely removed from the preparation. Thus, the muscle fibers were isolated 
from any stimulus and source of drive, while also completely bypassing the NMJ so that the 
muscle activity could be independently measured.  
Normally the NMJ releases the excitatory neurotransmitter glutamate onto the muscle to 
cause a contraction (Delgado et al., 2000). Since the activity from the NMJ was eliminated, the 
muscle was artificially stimulated using a Picospritzer II (General Valve Corporations, Fairfield, 
NJ) to puff glutamate at 10-4M from an electrode (Glass, Standard, 1.0 MM x .5) cut with a tip of 
about 15μm (Figure 7). The puff (pressure of 20psi and duration of 200ms) was administered on 
a singular muscle fiber to induce contraction of that fiber (Aonuma et al., 1998).  
Desensitization of the muscle from glutamate was observed when an alternative method 
was initially used. Here, glutamate (10-3 M) was superfused over the muscle for 15-30 seconds 
every three minutes (based on methods in Lingle (1980)). However, there was a clear decrease in 
the muscle contraction with every superfusion, which was predicted to be attributed to the 
muscle desensitization to glutamate (Titlow & Robin, 2018). This issue was resolved by 
transitioning to the puffing method and using a lower concentration of glutamate.  
Once the muscle showed a clear response to the glutamate, glutamate puffs were 
repeatedly delivered every 100 seconds using a Grass S88 Stimulator (Grass Inst. Co., Quincey, 
MA), to avoid the desensitization of the muscle fiber. When the muscle was stabilized, 
myosuppressin (10-7 M) was superfused over the muscle for 20 minutes, to record its response on 
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the cardiac muscle. After myosuppressin, the preparation underwent a 40-minute-long saline 
wash to ensure that all the myosuppressin was eliminated from the preparation before continuing 
experimentation. During the saline wash, glutamate was still repeatedly puffed. Only 
preparations in which responses returned approximately to baseline were analyzed.  
As a control, lobster saline was puffed onto the muscle to ensure that the mechanical 
force of the puff application did not cause a muscle contraction. 
2.3.5- Data Recording and Analysis 
Analogue signals were digitalized at 10kHz using a Micro 1401 (CED, Milton, 
Cambridge, UK) and recorded on Spike 2v7 (software; CED, Milton, Cambridge, UK). 
Neuromuscular Junction 
The amplitudes of the three stimulated EJPs (EJP 1, EJP 2, EJP 3) were measured by 
using the “peak finder” function and the “minimum value” function in Spike 2. Since the EJPs 
showed facilitation, I analyzed them as three separate groups: EJP 1, 2, and 3 in each condition 
(e.g. saline control, myosuppressin, and wash).  
For each heart preparation (N=6), amplitudes of the twelve sets of three stimulated EJPs 
from 1-120 seconds prior to myosuppressin superfusion were averaged, as were the amplitudes 
of the twelve EJP sets recorded 600-720 seconds after that start of myosuppressin superfusion.  
Cardiac Muscle 
The glutamate-evoked contraction amplitude was measured using a custom script that 
found the maximum value of the force (in grams) after each glutamate puff. To analyze the 
contraction change between saline and myosuppressin, the amplitudes of four stimulated 
contractions, elicited 300-700 seconds before the onset of myosuppressin superfusion, were 
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measured, as were contractions stimulated from 600-1000 seconds after the onset of 
myosuppressin superfusion (N=5). 
2.3.6- Neuromuscular Junction and Cardiac Muscle: Statistical Analysis 
Prism v7.0 was used for statistical analysis and graphing (GraphPad Software, Inc., San 
Diego, California). Using a paired t-test, the significance between saline and myosuppressin was 





Chapter 3: Results 
3.1- Bioinformatics 
Using the bioinformatics workflow, the sites and sources of modulation of a variety of 
neuropeptides and their corresponding receptors were predicted.  
3.1.1- Neuropeptides in the Cardiac Ganglion 
 Using the “cardiac ganglion combo” transcriptome, which includes both the pacemaker 
interneurons and the motor neurons, twenty-five neuropeptides were analyzed to determine their 
expression in the cardiac ganglion (Table 1). Of the neuropeptides searched for, sequences 
encoding RNA were identified in the cardiac ganglion transcriptome for the following: C-type 
allatostatin (AST-C), myosuppressin, proctolin, red pigment concentrating hormone (RPCH), 
and tachykinin (CabTRP) (Table 2). These neuropeptides are predicted to be synthesized and 
released from the neurons within the cardiac ganglion. 
3.1.2- Receptors in the Cardiac Ganglion and Cardiac Muscle 
 Using the cardiac ganglion combo transcriptome, twenty-three receptors were analyzed to 
determine their expression in the cardiac ganglion (Table 3). In the cardiac ganglion combo 
transcriptome, of the receptors analyzed, sequences encoding RNA were present for those of the 
following neuropeptides and amines: adipokinetic hormone-corazonin-like peptide (ACP), AST-
C, buscicon, CCAP, diuretic hormone 31 (DH31), diuretic hormone 44 (DH44), myosuppressin, 
octopamine (β receptor), proctolin, pyrokinin, and serotonin (Table 4). All eleven receptors were 
identified as 7 transmembrane receptors and were predicted to be GPCRs. 
Using the cardiac muscle transcriptome, twenty-two receptors were analyzed to 
determine their expression in the cardiac muscle (Table 3).  The receptors sequences encoding 
RNA in the cardiac muscle transcriptome were present for those of the following neuropeptides 
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and amines: AST-C, bursicon, DH31, DH44, myosuppressin, octopamine β, and serotonin (Table 
5). All seven receptors were predicted to be 7 transmembrane GPCRs.  
Since there can be multiple receptors for each neuropeptide, the specific receptor variants 
are listed in Table 4 and 5. The percent identities to the query sequences for each present 
neuropeptide and receptor identified in these transcriptomes are also indicated in Tables 2, 4, and 
5. 
3.1.3- Intrinsic and extrinsic modulation 
 From the bioinformatics workflow, AST-C and myosuppressin were predicted to be 
intrinsic modulators. AST-C and myosuppressin were also predicted to be the only two (of those 
analyzed) that might function as locally released extrinsic modulators. This suggests that many 
of the other neuromodulators analyzed that have receptors located in the cardiac neuromuscular 
system are released and synthesized in other systems of the lobster, such as the paracardial organ 
or the eyestalk. However, since transcriptomes are often incomplete, it is possible that this 
transcriptome did not include the sequences that are linked with the putative proteins of interest.   
3.1.4- Myosuppressin 
 Five protein sequences that appear to be homologous to myosuppressin receptors (MSR- 
I, II, III, IV, V) in other systems have been identified in the lobster nervous system (Oliesky et 
al., 2020). For MSR IV, three variants were identified. MSR II-IV (all variants) were found in 
the cardiac ganglion. I further investigated the MSRs and corroborated the results reported in 
Oliesky et al. (2020), identifying MSR II-IV (all variants) in the cardiac ganglion. The MSRs 
that were identified by Oliesky et al. (2020) had a partial or full alignment with the query 
sequences with a 100 percent identity. In the present study, only MSR IV (variant 1 and 2) was 
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identified in the cardiac muscle, with both variants being partial sequences. Both variants 
showed 100 percent identity with the query sequences. 
3.2- Physiological Experiments 
3.2.1- Myosuppressin does not act at the neuromuscular junction  
Since MSRs were predicted to be present in both cardiac ganglion and cardiac muscle 
tissue, it was hypothesized that these receptors may be expressed at the presynaptic and/or 
postsynaptic terminal of the NMJ, where myosuppressin binding could result in enhanced EJP 
amplitude. Figure 8 shows that the mean EJP amplitudes recorded in control saline and during 
the superfusion of 10-7M myosuppressin did not differ for any of the three consecutively 
stimulated EJPs (paired t-test, p < 0.05; N=6). These data suggest that myosuppressin does not 
act at the NMJ. 
3.2.2- Myosuppressin Cardiac Muscle Results  
 Since MSRs were predicted to be present in cardiac muscle tissue, it was hypothesized 
that these receptors may be expressed at the muscle, where myosuppressin binding could result 
in altered muscle contraction. To test this, I applied myosuppressin at a concentration of 10-7M 
over the muscle while recording from a single fiber. Figure 9 shows that myosuppressin induced 
an increase in glutamate-evoked contractions of the cardiac muscle. Peak contraction amplitude 
occurred around 600 seconds after myosuppressin was applied and then during the saline wash 
the amplitude decreased steadily. There was an increase in the mean amplitude of the glutamate-
evoked contractions when myosuppressin (10-7M) was superfused compared to control saline 
(paired t-test, p < 0.05; N=5) (Figure 10). These data suggest that myosuppressin is acting at the 




Chapter 4: Discussion  
A number of neuromodulators have been shown to exert effects on the lobster cardiac 
neuromuscular system; of these, several have been found to exert effects on the NMJ and/or the 
cardiac muscle (e.g. Wilkens et al., 2005; Dickinson et al., 2015). One of these neuromodulators 
is proctolin, which is known to modulate both the NMJ and the muscle (Wilkens et al., 2005). 
Surprisingly, in my investigation of the cardiac muscle transcriptome, RNA encoding the 
proctolin receptor was not found. However, that does not mean proctolin cannot act at the 
muscle, as shown in Wilkens et al. (2005). Instead, it suggests that the cardiac muscle 
transcriptome is incomplete. Since both myosuppressin and proctolin enhance contractions of the 
intact heart, it may be possible that they use analogous mechanisms, in which case we might 
expect them to exert effects at the periphery similarly. Interestingly, while myosuppressin did not 
appear to modulate at the NMJ, I show that myosuppressin exerts effects directly on the cardiac 
muscle. However, since there was a small sample size for analyzing the effects of myosuppressin 
on both the NMJ and the cardiac muscle, these are preliminary results that can be further studied 
using the same methodology. 
4.1- Proctolin modulates the NMJ via altered membrane resistance and regulates the cardiac 
muscle via L-type Ca2+ channels 
Proctolin was found to cause an increase in the muscle membrane resistance at the 
postsynaptic membrane, leading to an increase in EJP amplitude (Erxleben et al., 1995). 
Conversely, my results which indicate that myosuppressin does not modulate the EJPs and, thus, 
it seems unlikely to alter muscle resistance. Muscle membrane resistance was not measured in 
this experiment. However, there was no obvious, observable change in membrane potential when 
myosuppressin was applied (data not shown).  
23 
 
To examine the effect of myosuppressin on calcium dynamics in the muscle, one can 
measure changes in the Ca2+ concentration, using a fluorescent calcium indicator similar to 
methods used in Wilkens et al. (2005). They show that the extent to which the cardiac muscle 
contracted with proctolin was proportional to an increase in Ca2+. These data suggest that 
proctolin affects the Ca2+ dynamics; however, the mechanism of action remains unclear. 
This method would inform us about whether Ca2+ does play a role in modulation. 
Wilkens et al. (2005) shows that the cardiac muscle had an enhanced muscle force during 
proctolin application, results that are similar to the effect myosuppressin had on the cardiac 
muscle. There are at least two processes that could underlie this phenomenon: modulation of T-
type Voltage gated Ca2+ channels or Ca2+ release from L-type Ca2+ channels in the sarcoplasmic 
reticulum (SR). Proctolin does not affect the T-type Ca2+ channels. In the presence of T-type 
Ca2+ blockers (nifedipine, verapamil, and Cd2+), proctolin still enhanced contraction, showing the 
T-type Ca2+ receptors are not sufficient to drive the proctolin-induced increase in contraction. 
However, with ryanodine, which is a L-type Ca2+ blocker, they found that contraction was 
suppressed even with application of proctolin, suggesting that proctolin needs the sequestered 
Ca2+ from the SR to cause enhanced contraction. Moreover, when they applied proctolin and 
caffeine, which elicits Ca2+ release from the SR, there was a faster and stronger proctolin-
induced contraction in comparison to when caffeine was not present. This suggests that the Ca2+ 
release from L-type Ca2+ channels mediate the effect of proctolin on the muscle. Performing a 
similar experiment using myosuppressin would aid in determining whether Ca2+ dynamics are 
altered by activation of myosuppressin receptors in the cardiac muscle of the lobster. 
 Myosuppressin receptor IV (variants 1 and 2) was predicted to be located at the cardiac 
muscle. Pfam and Topcons predicted these variants to be GPCRs based on their characteristic 7 
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transmembrane structure. Many GPCRs activate secondary messenger pathways that can alter 
calcium dynamics within the muscle, which would allow them to modulate the contraction. In 
vertebrate cardiac muscle, the cAMP pathway usually elicits muscle contraction (Kuo & Ehrlich, 
2015). Myosuppressin GPCRs are not well understood. However, in Drosophila, proctolin 
GPCRs were found to modulate cardiac muscle contraction through activation of both cAMP and 
IP3 pathways (Hiripi et al., 1979; Lange, 1988; Hinton & Osborne, 1996; Baines et al., 1990). 
Both pathways activate the release of Ca2+ from the SR, which supports evidence that proctolin 
mediates sequestered Ca2+ release as observed by Wilkens et al. (2005). 
As mentioned, myosuppressin could be eliciting a variety of different mechanisms, 
including activation of secondary messengers, altered calcium dynamics in the muscle, or both. 
Another possibility is that myosuppressin could indirectly mediate ion channels through 
activating the G-protein. However, this is unlikely, since there was no obvious change in the 
membrane potential with myosuppressin (data not shown). Membrane potential was not 
measured in this experiment, so future research could be done looking at this parameter for more 
insight on the G-protein pathway. Myosuppressin could also affect a combination of these 
mechanisms listed and that combination could result in the response seen at the cardiac muscle. 
4.2- Myosuppressin is a FMRFamide-like peptide 
 Myosuppressin is part of the larger FMRFamide-like peptide (FLP) family. 
Myosuppressin has been shown to have inhibitory effects, however, in the American lobster, 
myosuppressin drives responses with an excitatory component in the cardiac neuromuscular 
system of the American lobster (Tanaka, 2016; Stevens et al. 2009). Activated FRMFamide 
GPCRs have been studied in the cardiac muscle of the squid (Loligo forbesii) and were found to 
alter calcium in the cardiac muscle (Chrachri et al., 2000). In the squid, there are two types of 
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cardiac muscle—type I, which is a smooth surfaced membrane while type II has a more 
invaginated surfaced membrane. FLPs act on the L-type Ca2+ channels, but not on T-type Ca2+ 
channels in both muscle types. Interestingly, the two muscle types responded to FLP differently. 
In type I cardiac muscle, FLP suppressed the L-type Ca2+ channels through a GPCR pathway 
and, in type II muscles, FLP caused a calcium current influx, which was not triggered by a 
GPRC (Chrachri et al., 2000). Since myosuppressin shares similar structural elements to FLPs 
and is known to cause increased contractile responses in the cardiac muscle, the altered Ca2+ 
dynamics caused by myosuppressin may be similar to that seen from FLP acting on the type II 
muscle. However, the myosuppressin receptor has also been predicted to be a GPCR, thus 
resembling the pathway that resulted in the suppression of contraction seen in type I muscle. 
Information about the membrane surface structure of the cardiac muscle in the American lobster 
is not known, so it is unclear whether the muscle would resemble type I or II squid cardiac 
muscle more closely. Moreover, FLPs have differing effects on the varying cardiac muscle due 
to the complexity of downstream receptor pathways. Experiments are needed to confirm 
myosuppressin receptors as GCPRs, through observing expression of common secondary 
messengers like cAMP and IP3. Furthermore, studying the structure of the cardiac muscle in the 
American lobster would contribute to the understanding of its commonalities with squid cardiac 
muscle.  
4.3- Differing Effects of Neuromodulators Based on Receptor Variants and Distribution 
It is possible that the multiple myosuppressin receptors could exert different effects 
through varying G-protein or other signaling pathways. For instance, in the stomatogastric 
nervous system of Cancer borealis, serotonin released from the same presynaptic neuron drove 
different responses in three postsynaptic neurons: LG, MCN1 axon terminals, and DG (Delong et 
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al., 2009; Kiehn et al., 1992; Powell et al. 2020). It is hypothesized that the serotoninergic-
mediated responses were distinct based on the types of 5-HT receptors expressed by these 
neurons. It has also been hypothesized that the distribution of those different receptors in the 
tissue lead to unique responses in different cells. Oliesky et al. (2020) found that myosuppressin, 
when acting on the pacemaker interneurons and the motor neurons separately, produced differing 
responses. They hypothesized that this could be attributed to the varying distribution of the 
myosuppressin receptors I-V, alongside the hypothesis that the receptors also exert different 
effects.  
4.4- Myosuppressin may alter the neuromuscular transform  
Because the cardiac neuromuscular system of the lobster is subject to stretch-induced 
positive-feedback and the nitric oxide negative-feedback, understanding more about how 
myosuppressin modulates contractions would provide further insight into how the heartbeat is 
regulated in these animals. For instance, we know that modulation of the cardiac ganglion output 
alters the heart contraction amplitude through the non-linear neuromuscular transform (NMT) 
(Williams, 2013). The NMT is the activity that results from specific motor neuronal patterns 
transforming into muscle contractions. Mapping the NMT activity allows inferences to be made 
about whether there is facilitation or defacilitation of muscle contractions, providing information 
that can help us understand how modulators exert their effects. William et al. (2013) mapped the 
NMT activity by observing how the contraction amplitude depended on duty cycle and burst 
frequency. Although the NMT is non-linear, the cardiac muscle showed stronger contractions 
with decreased cycle frequency and duty cycle. Myosuppressin is known to increase the burst 
duration while decreasing the duty cycle and cycle frequency of action potential bursts in the 
isolated cardiac ganglion (Stevens et al., 2009). Based on Williams et al. (2013), the burst 
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activity of myosuppressin would increase contraction amplitude. This trend has been specifically 
attributed to facilitation of contractions due to the decreased duty cycle for contraction 
(Williams, 2013; Stevens et al., 2009). Through understanding the relationship between the 
neural circuits and the motor outputs, there can be a greater understanding of how these complex 
pattern generators are modulated. 
4.5- Other Neuromodulators’ Effects on the Periphery of the Cardiac Neuromuscular System 
AST-C is one of the neuromodulators that has been analyzed in an isolated periphery 
(Wiwatpanit et al., 2012). There are four receptors that have been predicted to be in the cardiac 
neuromuscular system based on homologous sequences to AST-C receptors in other systems. Of 
those four, receptor 1 and 2 have been shown to be functional, while receptor 3 and 4 have been 
found to be non-functional (Walsh, 2017; J. Joe Hull, personal communication). In my 
investigation of the cardiac muscle, I predicted that receptor 1 and 2 were expressed in cardiac 
muscle (Table 5). Interestingly, Wiwatpanit et al. (2012) found that AST-C did not alter activity 
at the NMJ or cardiac muscle. These results reveal that receptors predicted to be expressed at the 
cardiac muscle using bioinformatics, does not necessarily mean that they modulate the heartbeat. 
These receptors could act in other ways such as, regulating metabolism or mediating another 
system that cannot be physiologically recorded at present. The receptors could also be expressed 
conditionally or be non-functional in the cardiac muscle. 
 Little is known concerning the mechanisms by which other neuromodulators actually 
modulate the NMJ or muscle fibers. GYS and SGRN are two peptides that have been studied in 
the American lobster; both were found to cause an increase in contraction amplitude at the 
periphery, but it is still unknown whether they exert effects at the NMJ and/or the cardiac muscle 
(Dickinson et al., 2015). Other neuropeptides that have been found to have enhancing effects on 
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the cardiac neuromuscular system by increasing both the amplitude and frequency of the heart 
contraction in whole heart preparations, include DH31, sulkakinin, octopamine, and to a lesser 
extent tyramine (Christie et al., 2010; Dickinson et al., 2007; unpublished data by Anthony 
Yanez). My data show that both DH31 and octopamine are predicted to have receptors located in 
the cardiac muscle. In future research, similar methodology to the myosuppressin experiments 
described here could be used to discover if GYS and/or SGRN modulate the periphery through 
the NMJ, muscle, or both. Additionally, other modulators such as DH31, octopamine, sulkakinin, 
and tyramine could be investigated in this way. Using the CPG-effector system to study the 
mechanisms of modulation will give us a greater understanding of neuronal circuits at large and 
















Chapter 5: Figures and Tables  
 
 
Figure 1. A ventral view of the cardiac neuromuscular system of the lobster. The Y shape of 
the cardiac ganglion is illustrated, with the motor neurons in red and the pacemaker interneurons 
in green. The two ovals over the two branches of the “Y” are the ostia where hemolymph enters 
the heart. The arteries are located at the posterior and anterior end of the system (Dickinson et 
















Figure 2. A schematic diagram of the CPG-effector system and its closed feedback system. 
The nitric oxide response is a negative feedback pathway while a stretch sensitive response is a 
positive feedback pathway. Neuromodulators that modulate at the level of the CPG, NMJ, or 










Figure 3. Example of the facilitation of EJPs. A nerve was stimulated with ten identical pulses 


















Figure 4. Myosuppressin increases amplitude and decreases frequency of the muscle 
contraction in the whole heart of the American lobster. An example of a whole heart 
recording with myosuppressin at 10-6M (application illustrated by the black line). The recording 























Figure 5. Myosuppressin caused an increase in contraction more than double the 
contraction at baseline in the periphery of the cardiac neuromuscular system of the 
American lobster. (A) An example recording of the heart’s contractile force at just the 
periphery. The periphery was isolated through removing the cardiac ganglion and then the motor 
nerve was stimulated thirteen times at 60Hz with 300ms bursts. (B) With a higher speed 
recording, there is a visible increase in the contractile force with myosuppressin (black) 
compared to baseline (green) from the start stimulation (orange) to the end of the thirteen bursts. 
The recording measures force in grams on the y axis and time in seconds on the x axis (Stevens 





















Figure 6. Comparing endogenous EJPs to stimulated EJPs. (A) Spontaneous excitatory 
junction potentials (EJPs) are a result of bursts of action potentials coming from the intact 
cardiac ganglion. (B) Recording of excitatory junction potentials (EJPs) at the neuromuscular 
junction (NMJ) when the cardiac ganglion was removed, so the neural activity at the NMJ was 
isolated. Each EJP results from a single stimulus to the motor nerve—indicated by the black 


















Figure 7. Experimental set up for measuring glutamate-evoked contractions from the 
cardiac muscle (an experiment model modified from Matthew Maguire’s thesis (2019)). The 
muscle end holders have hooks, which held the cardiac muscle bundle in place. The white 
patches where the hooks meet the muscle are representative of the GluTru that helped in holding 
the muscle in place. The force transducer then placed on the center of the muscle bundle, which 
measured the contraction force of the cardiac muscle. The glass microelectrode, represented by 
the clear triangle attached to the salmon colored electrode holder, was filled with glutamate and 
puffed onto the muscle fiber that was being measured by the force transducer. Note the removed 




















































































































Figure 8. Myosuppressin caused no significant change in EJP amplitude at the 
neuromuscular junction in the heart of the American lobster. The mean amplitude of 
stimulated (a) EJP 1, (b) EJP 2, and (c) EJP 3 was calculated from the saline control (teal; EJP 1 
(5.62 ± 3.69), EJP 2 (5.11 ± 3.42), EJP 3 (5.41 ± 3.45)) and the application of 10-7M 
myosuppressin (orange; EJP 1 (5.01 ± 2.54), EJP 2 (4.46 ± 1.91), EJP 3 (4.50 ± 2.06)). There 
was no significant difference in the amplitude of EJPs between control and myosuppressin (p> 







Figure 9. Myosuppressin resulted in an increase in the amplitude of glutamate-evoked 
contractions when the endogenous cardiac ganglion activity was eliminated. Both 
contractions were stimulated by a glutamate (10-4M) puff, the time of these puffs is indicated by 
the blue arrows. The recording measures the force in grams (g) on the y-axis and time in seconds 































































Figure 10. Myosuppressin increased glutamate-evoked contraction amplitude in the isolated 
cardiac muscle. The mean glutamate-evoked contraction amplitude from the isolated cardiac 
muscle in control saline (blue; 0.00158 ± 0.00049) and in myosuppressin 10-7M (green; 0.002 ± 
0.00050). Contraction amplitude to myosuppressin application in response to glutamate puff 


















AST-B   -^ 
AST-C + 
Bursicon A - 
Bursicon B - 
CabTRP + 
CCAP - 
CCHamide 2 - 
Corazoin - 
DH31   -* 















Table 1. Summary of the predictions made about whether the neuropeptide is synthesized 
and released in the cardiac ganglion using the H. americanus cardiac ganglion combo 
transcriptome. Those neuropeptides that were predicted to be synthesized and released at the 
cardiac ganglion are indicated by ‘+,’ while those that were not are indicated by ‘-.’  
* - Alignment was inconclusive  
















Table 2. Compiled data about the putative neuropeptides predicted to be synthesized and 
released in the cardiac ganglion. Predictions were based on the neuropeptide’s sequence 
alignment to their query sequence. The trinity number is an identifier for a nucleotide sequence 
in the cardiac ganglion combo transcriptome of H. americanus. The trinity numbers that are 
grouped by color are identical protein sequences. Percent identity was calculated by the number 
of matching amino acids over the number of total amino acids (that overlapped with the putative 























Neuropeptide Trinity Number Completeness 
of transcript 
Percent Identity 
AST-C TR71619|c0_g1_i1 Partial 91.4 
CabTRP TR91706|c0_g1_i2 Partial 100  
TR91706|c0_g1_i1 Partial 100 
Myosuppressin TR26925|c0_g1_i3 Full 100  
TR26925|c0_g1_i2 Full 100  
TR26925|c0_g1_i1 Full 100 
Proctolin TR46909|c0_g1_i2 Full 100  
TR46909|c0_g1_i1 Full 100 
RPCH TR68520|c0_g1_i1 Full 100 
41 
 
Receptor CM CG 
ACP - + 
AST-A - - 
AST-C + + 
Bursicon + + 
CCAP - + 
CCHamide   -*   -* 
Corazoin - - 
DH31 + + 
DH44 + + 
EFLamide 0 - 
FMRFamide - - 
Myosuppressin + + 
Proctolin   -* + 
Pyrokinin - + 
RPCH - - 
SIFamide - - 
Sulfakinin - - 
Tackykinin - - 
Amines 
  
Dopamine - 0 
Octopamine 0   -* 
Octopamine β + + 
OctTyr Combo - - 
Serotonin + + 
Tyramine   -*   -* 
 
Table 3. Summary of the presence of predicted receptors in the cardiac ganglion (CG) and 
the cardiac muscle (CM) using the tissue-specific transcriptomes of H. americanus. Those 
receptors that were predicted to be located at the cardiac ganglion/muscle are indicated by ‘+,’ 
while those that were not are indicated by ‘-.’  
* - Alignment was inconclusive  




Receptor Variant Trinity Number Completeness 
of transcript  
Percent Identity 
ACP Receptor 1 TR2344|c2_g3_i1 Partial 100  
Receptor 1 TR2344|c2_g3_i2 Partial 100 
AST-C Receptor 2 TR8916|c1_g2_i4 Full 100  
Receptor 2 TR8916|c1_g2_i2 Full 100  
Receptor 2 TR8916|c1_g2_i1 Full 100  
Receptor 4 TR56862|c4_g5_i1 Full 100  
Receptor 4 TR56862|c4_g4_i1 Full 100  
Receptor 4 TR56862|c4_g3_i1 Full 100  
Receptor 4 TR56862|c4_g2_i1 Full 100  
Receptor 4 TR56862|c4_g1_i1 Full 100 
Bursicon  Receptor 1 TR45425|c0_g1_i1 Partial 100  
Receptor 1 TR68968|c0_g1_i1 Partial 100 
CCAP Receptor 1 TR86078|c0_g1_i1 Partial 100  
Receptor 1 TR3748|c0_g1_i1 Partial 100 
 DH31 Receptor 1 TR7828|c0_g1_i1 Full 99.6  
Receptor 1 TR7828|c0_g1_i2 Partial 99.7 
DH44 Receptor 1 TR7124|c0_g1_i1 Partial 100  
Receptor 1 TR52110|c0_g1_i1 Partial 100  
Receptor 2 TR17601|c0_g1_i1 Partial 100  
Receptor 2 TR50316|c0_g1_i1 Partial 100  
Receptor 2 TR18146|c0_g1_i1 Partial 100 
Myosuppressin Receptor 2 TR22607|c0_g1_i3 Full 100  
Receptor 2 TR22607|c0_g1_i1 Partial 100  
Receptor 3 TR27825|c0_g1_i1 Partial 100  
Receptor 4 V1 TR38943|c0_g1_i4 Full 100  
Receptor 4 V1 TR38943|c0_g1_i3 Full 100  
Receptor 4 V1 TR38943|c0_g1_i1 Full 100  
Receptor 4 V2,3 TR38943|c0_g1_i4 Partial 100  
Receptor 4 V2,3 TR38943|c0_g1_i3 Partial 100  
Receptor 4 V2,3 TR38943|c0_g1_i1 Partial 100 
Proctolin Receptor 1 TR31134|c0_g2_i4 Full 99.8  
Receptor 1 TR31134|c0_g2_i3 Full 99.8  
Receptor 1 TR31134|c0_g2_i2 Full 99.8  
Receptor 1 TR31134|c0_g2_i1 Full 99.8  
Receptor 1 TR31134|c0_g2_i5 Partial 99.7  
Receptor 2 TR388|c0_g1_i2 Partial 100  
Receptor 2 TR388|c0_g1_i3 Partial 100  
Receptor 2 TR388|c0_g1_i1 Partial 100 
Pyrokinin Receptor 1 TR19456|c0_g1_i1 Partial 100 
Amines 
    




Receptor 2 TR7749|c0_g1_i1 Partial 100 
Serotonin Type 7 Receptor TR30021|c1_g2_i2 Full 100 
 Type 7 Receptor TR30021|c1_g2_i1 Full 100 
 
 
Table 4. Compiled data about the receptors predicted to be expressed in the cardiac 
ganglion, including the variants of the receptors. The trinity number is an identifier for a 
nucleotide sequence in the cardiac ganglion combo transcriptome of H. americanus. The trinity 
numbers that are grouped by color are identical protein sequences. Percent identity was 
calculated by the number of matching amino acids over the number of total amino acids (that 




































Table 5. Compiled data about the receptors predicted to be expressed in the cardiac muscle, 
including the variants of the receptors. The trinity number is an identifier for a nucleotide 
sequence in the cardiac muscle transcriptome of H. americanus. The trinity numbers that are 
grouped by color are identical protein sequences. Percent identity was calculated by the number 
of matching amino acids over the number of total amino acids (that overlapped with the putative 



















AST-C Receptor 1 TR42870|c0_g1_i1 Partial 83.4  
Receptor 2 TR42870|c0_g1_i1 Partial 100 
Bursicon  Receptor 1 TR22406|c0_g1_i1 Partial 100  
Receptor 1 TR27789|c0_g1_i1 Partial 100 
 DH31 Receptor 2 TR48162|c0_g1_i2 Partial 100  
Receptor 2 TR48162|c0_g1_i1 Partial 99.1 
DH44 Receptor 1 TR32466|c0_g1_i1 Partial 100 
Myosuppressin Receptor 4 Variant 1 TR17352|c0_g1_i1 Partial 100  
Receptor 4 Variant 2 TR17352|c0_g1_i1 Partial 100 
Amines 
    
Octopamine β Receptor 2 TR42209|c0_g1_i1 Partial 100  
Receptor 2 TR34866|c0_g1_i1 Partial 100 
Serotonin Type 7 Receptor TR54400|c0_g1_i1 Partial 98.7  
Type 7 Receptor TR40843|c0_g1_i1 Partial 100  
Type 7 Receptor TR14406|c0_g1_i2 Partial 100  
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Receptor 4 Variant 1 
TR38943|c0_g1_i4, TR38943|c0_g1_i3, TR38943|c0_g1_i1 
 
 
Receptor 4 Variant 2 






Receptor 4 Variant 3 





















































































































































































































































































































































































Receptor Type 7 
TR54400|c0_g1_i1 
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TR40843|c0_g1_i1 
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TR14406|c0_g1_i2, TR14406|c0_g1_i1 
 
 
